Viewing nowMontelukast Tablet 10 mg (Montelukast Sodium)
Montelukast Sodium 10.4mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

MFDS item code 201500962 · Approved 2015.02.25 · Insurance code 645208660
Prevention and maintenance treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medication helps prevent asthma attacks and manage asthma on an ongoing basis. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis.
This medicine is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the administration time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. Adults and adolescents aged 15 years and older: Administer montelukast 10 mg orally once daily. Adults and adolescents aged 15 years and older: Place montelukast 10 mg on the tongue once daily and allow it to dissolve; take without water.
Children aged 6~14 years: Chew montelukast 5 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew montelukast 4 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place montelukast 5 mg on the tongue once daily and take without water once it disintegrates. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place montelukast 4 mg on the tongue once daily and take without water once it disintegrates. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place montelukast 5 mg on the tongue once daily and allow it to dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place montelukast 4 mg on the tongue once daily and allow it to dissolve; take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer montelukast 5mg orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. Asthma - Children aged 2~5 years: Administer montelukast 4 mg orally once daily. Asthma - Infants aged 12 months~under 2 years: Administer this medicine 4 mg orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months. Allergic rhinitis - Children aged 2~5 years: Administer montelukast 4 mg orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years. Allergic rhinitis - Infants aged 6 months~under 2 years: Administer this medicine 4mg orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months.
This medicine contains aspartame, an artificial sweetener, which is broken down into phenylalanine in the body. Therefore, patients with phenylketonuria, a genetic disorder that requires restriction of phenylalanine intake, should not take this medication. Additionally, this medication contains lactose and should not be administered to patients with genetic issues such as galactose intolerance, lactose deficiency, or glucose-galactose malabsorption. This drug is used for the treatment of asthma or allergic rhinitis but cannot be used during an acute asthma attack, and separate emergency medications should always be kept on hand for acute symptom relief. Do not abruptly stop or replace inhaled corticosteroids while taking this medication, and dosage should be adjusted gradually according to a physician's instructions. During treatment, unusual reactions such as fatigue, headache, dyspepsia, cough, rash may occur, and if these symptoms arise, one should consult healthcare professionals. Patients taking this medication may experience neuropsychiatric symptoms, such as anxiety, depression, hallucinations, or suicidal thoughts, and should immediately inform a physician if such changes occur. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid using these medicines while taking this medication, and it is unclear whether this medication can treat asthma attacks in aspirin-sensitive asthma patients. If pregnant or breastfeeding, the safety of this medication has not been fully established, so it should be used only as deemed necessary by a physician. This medicine is also available for use in children and the elderly, but particularly in young children, the established age range for safety and efficacy should be followed, and caution is needed as seniors may respond differently to the medication. In the case of overdose, there is no specific antidote, so general treatment based on symptoms should be carried out and managed appropriately according to a physician's instructions. This medication is sensitive to light, so it should be taken immediately after opening, and stored out of reach of children. Finally, this medication should be taken consistently, even when asymptomatic, and dosages of other asthma treatments should not be decreased or discontinued arbitrarily while taking this.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air, moisture, and light. It is best to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness and prevent degradation.
Beige film-coated tablet in a rounded square shape
28 tablets/PTP (7 tablets x 4 PTP)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 10.4mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.